信息搜索
信息关键字：药
  

共有3954条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]

·以岭药业：连花清瘟获乌兹别克斯坦药物注册批文2021-1-14 11:51:15
·涉及十余家A股公司！国家药监局：酚酞片和酚酞含片停产、停售、停用2021-1-14 11:01:07
·诚意药业2020年预计净利1.6亿-1.68亿主营品种关节类产品收入同比增长2021-1-14 10:44:06
·延安必康：产能过亿制药项目即将运营助力药品扩产业绩有望提速2021-1-14 10:01:52
·兴齐眼药拟募资8亿加码主业近五成资金用于研发2021-1-14 8:50:11
·同舟共“冀”多地上市药企驰援河北2021-1-14 5:47:52
·科技创新和成果转化难？资本这样为医药企业破题2021-1-14 3:03:52
·金城医药业绩爆雷背后还有隐患2021-1-14 0:20:31
·奥翔药业2020年预计净利8500万-9600万特色原料药业务取得较快增长2021-1-14 0:03:53
·金城医药股东崔希礼减持2万股套现约80万元2021-1-13 22:18:59
·双鹭药业董事长兼总经理徐明波增持31.5万股耗资约289.8万元2021-1-13 22:06:56
·又要“准备”7.4亿，3年累计商誉减值将达11.5亿金城医药股价这几天不跌反涨2021-1-13 21:46:22
·为何国药控股董事长因个人原因辞职 国药控股股票会大跌吗？2021-1-13 17:41:52
·国药控股联公司董事长因个人原因辞职2021-1-13 17:29:04
·恒生指数收跌0.15%报28235点中国生物制药(01177)跌3%领跌蓝筹2021-1-13 17:07:55
·奥赛康：注射用艾司奥美拉唑钠通过仿制药一致性评价有利于进一步增强该药品技术优势2021-1-13 15:17:30
·一日内两高管辞任！国药控股董事长李智明及国药股份总经理李辉辞职均因“个人原因”2021-1-13 12:21:16
·“踩雷”金城泰尔金城医药跌进亏损泥潭2021-1-13 11:47:53
·金城医药18.8亿收购爆雷全年预亏5亿连续三年计提减值11.4亿商誉归零2021-1-13 11:10:28
·兴齐眼药抛出8亿元定增加码滴眼液近50%募资用于研发2021-1-13 10:57:32

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]